nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—Carcinoma of lung—Docetaxel—head and neck cancer	0.0781	0.0866	CcSEcCtD
Roflumilast—Lung neoplasm malignant—Docetaxel—head and neck cancer	0.0675	0.0748	CcSEcCtD
Roflumilast—PDE4C—tongue—head and neck cancer	0.0264	0.271	CbGeAlD
Roflumilast—Renal failure acute—Hydroxyurea—head and neck cancer	0.0205	0.0227	CcSEcCtD
Roflumilast—PDE4C—mouth—head and neck cancer	0.0177	0.182	CbGeAlD
Roflumilast—Depression—Vinblastine—head and neck cancer	0.016	0.0177	CcSEcCtD
Roflumilast—Infestation NOS—Hydroxyurea—head and neck cancer	0.0146	0.0162	CcSEcCtD
Roflumilast—Infestation—Hydroxyurea—head and neck cancer	0.0146	0.0162	CcSEcCtD
Roflumilast—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.0138	0.0153	CcSEcCtD
Roflumilast—Ill-defined disorder—Vinblastine—head and neck cancer	0.0116	0.0129	CcSEcCtD
Roflumilast—Malaise—Vinblastine—head and neck cancer	0.0113	0.0125	CcSEcCtD
Roflumilast—Vertigo—Vinblastine—head and neck cancer	0.0112	0.0124	CcSEcCtD
Roflumilast—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0106	0.0117	CcSEcCtD
Roflumilast—Pneumonia—Fluorouracil—head and neck cancer	0.0106	0.0117	CcSEcCtD
Roflumilast—Discomfort—Vinblastine—head and neck cancer	0.0105	0.0117	CcSEcCtD
Roflumilast—Infestation NOS—Fluorouracil—head and neck cancer	0.0105	0.0116	CcSEcCtD
Roflumilast—Infestation—Fluorouracil—head and neck cancer	0.0105	0.0116	CcSEcCtD
Roflumilast—Atrial fibrillation—Docetaxel—head and neck cancer	0.0104	0.0115	CcSEcCtD
Roflumilast—Malaise—Hydroxyurea—head and neck cancer	0.0103	0.0114	CcSEcCtD
Roflumilast—Urinary tract infection—Fluorouracil—head and neck cancer	0.0102	0.0113	CcSEcCtD
Roflumilast—Sinusitis—Fluorouracil—head and neck cancer	0.00985	0.0109	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00964	0.0107	CcSEcCtD
Roflumilast—Discomfort—Hydroxyurea—head and neck cancer	0.00959	0.0106	CcSEcCtD
Roflumilast—Rhinitis—Fluorouracil—head and neck cancer	0.00945	0.0105	CcSEcCtD
Roflumilast—Infection—Hydroxyurea—head and neck cancer	0.00924	0.0102	CcSEcCtD
Roflumilast—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00913	0.0101	CcSEcCtD
Roflumilast—Skin disorder—Hydroxyurea—head and neck cancer	0.00904	0.01	CcSEcCtD
Roflumilast—Decreased appetite—Vinblastine—head and neck cancer	0.00887	0.00983	CcSEcCtD
Roflumilast—Constipation—Vinblastine—head and neck cancer	0.00873	0.00967	CcSEcCtD
Roflumilast—Feeling abnormal—Vinblastine—head and neck cancer	0.00841	0.00932	CcSEcCtD
Roflumilast—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00834	0.00924	CcSEcCtD
Roflumilast—Dyspepsia—Hydroxyurea—head and neck cancer	0.00819	0.00908	CcSEcCtD
Roflumilast—Decreased appetite—Hydroxyurea—head and neck cancer	0.00809	0.00896	CcSEcCtD
Roflumilast—Abdominal pain—Vinblastine—head and neck cancer	0.00807	0.00894	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00803	0.0089	CcSEcCtD
Roflumilast—Fatigue—Hydroxyurea—head and neck cancer	0.00802	0.00889	CcSEcCtD
Roflumilast—Constipation—Hydroxyurea—head and neck cancer	0.00796	0.00882	CcSEcCtD
Roflumilast—Weight decreased—Docetaxel—head and neck cancer	0.00769	0.00852	CcSEcCtD
Roflumilast—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00767	0.0085	CcSEcCtD
Roflumilast—Pneumonia—Docetaxel—head and neck cancer	0.00762	0.00845	CcSEcCtD
Roflumilast—Infestation NOS—Docetaxel—head and neck cancer	0.00758	0.0084	CcSEcCtD
Roflumilast—Infestation—Docetaxel—head and neck cancer	0.00758	0.0084	CcSEcCtD
Roflumilast—Hypersensitivity—Vinblastine—head and neck cancer	0.00752	0.00833	CcSEcCtD
Roflumilast—Asthenia—Vinblastine—head and neck cancer	0.00732	0.00811	CcSEcCtD
Roflumilast—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00717	0.00794	CcSEcCtD
Roflumilast—Myalgia—Fluorouracil—head and neck cancer	0.00699	0.00774	CcSEcCtD
Roflumilast—Diarrhoea—Vinblastine—head and neck cancer	0.00698	0.00774	CcSEcCtD
Roflumilast—Discomfort—Fluorouracil—head and neck cancer	0.0069	0.00765	CcSEcCtD
Roflumilast—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00686	0.0076	CcSEcCtD
Roflumilast—Rhinitis—Docetaxel—head and neck cancer	0.00682	0.00756	CcSEcCtD
Roflumilast—Dizziness—Vinblastine—head and neck cancer	0.00675	0.00748	CcSEcCtD
Roflumilast—Connective tissue disorder—Docetaxel—head and neck cancer	0.00669	0.00741	CcSEcCtD
Roflumilast—Asthenia—Hydroxyurea—head and neck cancer	0.00668	0.0074	CcSEcCtD
Roflumilast—Infection—Fluorouracil—head and neck cancer	0.00665	0.00737	CcSEcCtD
Roflumilast—Nervous system disorder—Fluorouracil—head and neck cancer	0.00657	0.00728	CcSEcCtD
Roflumilast—Vomiting—Vinblastine—head and neck cancer	0.00649	0.00719	CcSEcCtD
Roflumilast—PDE4C—head—head and neck cancer	0.0064	0.0657	CbGeAlD
Roflumilast—Headache—Vinblastine—head and neck cancer	0.00639	0.00708	CcSEcCtD
Roflumilast—Diarrhoea—Hydroxyurea—head and neck cancer	0.00637	0.00705	CcSEcCtD
Roflumilast—PDE4D—thyroid gland—head and neck cancer	0.00635	0.0652	CbGeAlD
Roflumilast—Cardiac disorder—Docetaxel—head and neck cancer	0.00632	0.007	CcSEcCtD
Roflumilast—Dizziness—Hydroxyurea—head and neck cancer	0.00615	0.00682	CcSEcCtD
Roflumilast—Immune system disorder—Docetaxel—head and neck cancer	0.00615	0.00681	CcSEcCtD
Roflumilast—Mediastinal disorder—Docetaxel—head and neck cancer	0.00613	0.00679	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0061	0.00676	CcSEcCtD
Roflumilast—Nausea—Vinblastine—head and neck cancer	0.00606	0.00672	CcSEcCtD
Roflumilast—Insomnia—Fluorouracil—head and neck cancer	0.00606	0.00671	CcSEcCtD
Roflumilast—Mental disorder—Docetaxel—head and neck cancer	0.00596	0.00661	CcSEcCtD
Roflumilast—Malnutrition—Docetaxel—head and neck cancer	0.00592	0.00656	CcSEcCtD
Roflumilast—Vomiting—Hydroxyurea—head and neck cancer	0.00592	0.00656	CcSEcCtD
Roflumilast—Dyspepsia—Fluorouracil—head and neck cancer	0.0059	0.00653	CcSEcCtD
Roflumilast—Rash—Hydroxyurea—head and neck cancer	0.00587	0.0065	CcSEcCtD
Roflumilast—Dermatitis—Hydroxyurea—head and neck cancer	0.00586	0.00649	CcSEcCtD
Roflumilast—Headache—Hydroxyurea—head and neck cancer	0.00583	0.00646	CcSEcCtD
Roflumilast—Decreased appetite—Fluorouracil—head and neck cancer	0.00582	0.00645	CcSEcCtD
Roflumilast—Dysgeusia—Docetaxel—head and neck cancer	0.0058	0.00643	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00578	0.00641	CcSEcCtD
Roflumilast—PDE4B—parotid gland—head and neck cancer	0.00573	0.0588	CbGeAlD
Roflumilast—Back pain—Docetaxel—head and neck cancer	0.00573	0.00635	CcSEcCtD
Roflumilast—Muscle spasms—Docetaxel—head and neck cancer	0.0057	0.00631	CcSEcCtD
Roflumilast—PDE4A—thyroid gland—head and neck cancer	0.00562	0.0577	CbGeAlD
Roflumilast—Nausea—Hydroxyurea—head and neck cancer	0.00553	0.00612	CcSEcCtD
Roflumilast—Feeling abnormal—Fluorouracil—head and neck cancer	0.00552	0.00612	CcSEcCtD
Roflumilast—PDE4B—saliva-secreting gland—head and neck cancer	0.00549	0.0564	CbGeAlD
Roflumilast—Urticaria—Fluorouracil—head and neck cancer	0.00532	0.0059	CcSEcCtD
Roflumilast—Palpitations—Docetaxel—head and neck cancer	0.00523	0.0058	CcSEcCtD
Roflumilast—Myalgia—Docetaxel—head and neck cancer	0.00504	0.00559	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00501	0.00555	CcSEcCtD
Roflumilast—Hypersensitivity—Fluorouracil—head and neck cancer	0.00493	0.00547	CcSEcCtD
Roflumilast—Infection—Docetaxel—head and neck cancer	0.0048	0.00532	CcSEcCtD
Roflumilast—Nervous system disorder—Docetaxel—head and neck cancer	0.00474	0.00525	CcSEcCtD
Roflumilast—Skin disorder—Docetaxel—head and neck cancer	0.0047	0.0052	CcSEcCtD
Roflumilast—Diarrhoea—Fluorouracil—head and neck cancer	0.00458	0.00508	CcSEcCtD
Roflumilast—Dizziness—Fluorouracil—head and neck cancer	0.00443	0.00491	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.0044	0.00488	CcSEcCtD
Roflumilast—Insomnia—Docetaxel—head and neck cancer	0.00437	0.00484	CcSEcCtD
Roflumilast—Vomiting—Fluorouracil—head and neck cancer	0.00426	0.00472	CcSEcCtD
Roflumilast—Dyspepsia—Docetaxel—head and neck cancer	0.00426	0.00471	CcSEcCtD
Roflumilast—PDE4B—trachea—head and neck cancer	0.00424	0.0435	CbGeAlD
Roflumilast—Rash—Fluorouracil—head and neck cancer	0.00422	0.00468	CcSEcCtD
Roflumilast—Dermatitis—Fluorouracil—head and neck cancer	0.00422	0.00467	CcSEcCtD
Roflumilast—Decreased appetite—Docetaxel—head and neck cancer	0.0042	0.00466	CcSEcCtD
Roflumilast—Headache—Fluorouracil—head and neck cancer	0.0042	0.00465	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00417	0.00462	CcSEcCtD
Roflumilast—Fatigue—Docetaxel—head and neck cancer	0.00417	0.00462	CcSEcCtD
Roflumilast—Constipation—Docetaxel—head and neck cancer	0.00413	0.00458	CcSEcCtD
Roflumilast—Feeling abnormal—Docetaxel—head and neck cancer	0.00398	0.00441	CcSEcCtD
Roflumilast—Nausea—Fluorouracil—head and neck cancer	0.00398	0.00441	CcSEcCtD
Roflumilast—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00395	0.00438	CcSEcCtD
Roflumilast—PDE4D—lymph node—head and neck cancer	0.00395	0.0405	CbGeAlD
Roflumilast—Abdominal pain—Docetaxel—head and neck cancer	0.00382	0.00423	CcSEcCtD
Roflumilast—PDE4B—lymphoid tissue—head and neck cancer	0.00369	0.0379	CbGeAlD
Roflumilast—Hypersensitivity—Docetaxel—head and neck cancer	0.00356	0.00395	CcSEcCtD
Roflumilast—PDE4A—lymph node—head and neck cancer	0.00349	0.0358	CbGeAlD
Roflumilast—Asthenia—Docetaxel—head and neck cancer	0.00347	0.00384	CcSEcCtD
Roflumilast—PDE4B—thyroid gland—head and neck cancer	0.00335	0.0344	CbGeAlD
Roflumilast—Diarrhoea—Docetaxel—head and neck cancer	0.00331	0.00366	CcSEcCtD
Roflumilast—Dizziness—Docetaxel—head and neck cancer	0.0032	0.00354	CcSEcCtD
Roflumilast—Vomiting—Docetaxel—head and neck cancer	0.00307	0.00341	CcSEcCtD
Roflumilast—Rash—Docetaxel—head and neck cancer	0.00305	0.00338	CcSEcCtD
Roflumilast—Dermatitis—Docetaxel—head and neck cancer	0.00305	0.00337	CcSEcCtD
Roflumilast—Headache—Docetaxel—head and neck cancer	0.00303	0.00336	CcSEcCtD
Roflumilast—PDE4B—head—head and neck cancer	0.00297	0.0305	CbGeAlD
Roflumilast—Nausea—Docetaxel—head and neck cancer	0.00287	0.00318	CcSEcCtD
Roflumilast—PDE4B—lymph node—head and neck cancer	0.00208	0.0214	CbGeAlD
